Last reviewed · How we verify
Superficial Ocular Infection
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Cortisporin · Pfizer
- Klaron · Merck & Co.
- Chlorocidin · Parkedale
- Cortone
- E-Mycin · Generic (originally Abbott/Lilly)
- Zestril · Generic (originally Merck/AstraZeneca)
Inhibits angiotensin-converting enzyme (ACE), preventing conversion of angiotensin I to angiotensin II, lowering blood pressure and reducing cardiac workload. - Cortisporin · Pfizer
- Cortef · Generic (originally Merck/Upjohn)
- Cortisporin · Pfizer
- Benzamycin · Pfizer
- Gramoderm · Pfizer
- Cortisol · University of Zurich
- Prelone · Generic (originally Schering)
- prednisolon · Hannover Medical School
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Superficial Ocular Infection patent landscape — cliff calendar, originator estates, attackable patents
- Superficial Ocular Infection treatment landscape brief
- Superficial Ocular Infection treatment updates RSS
Frequently asked questions about Superficial Ocular Infection
What drugs treat Superficial Ocular Infection?
Tracked treatments include Ramycin, Cortisporin, Klaron, Chlorocidin, Cortone, E-Mycin, Zestril, Cortef.
What is the treatment for Superficial Ocular Infection?
Standard treatment for Superficial Ocular Infection includes Ramycin, Cortisporin, Klaron, Chlorocidin, Cortone. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Superficial Ocular Infection patent cliff · Superficial Ocular Infection CI report
- Treatment: Ramycin
- Treatment: Cortisporin · Pfizer
- Treatment: Klaron · Merck & Co.
- Treatment: Chlorocidin · Parkedale
- Treatment: Cortone
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing